Rajgopal G
Classified Specialist in Surgery and Surgical Oncology, MDTC, Command Hospital (SC), PUNE - 411 040.
Med J Armed Forces India. 1994 Jan;50(1):49-55. doi: 10.1016/S0377-1237(17)31038-9. Epub 2017 Jun 27.
Soft-tissue sarcomas are locally aggressive tumours with a tendency to spread haematogenously, especially to the lungs. Most patients present without obvious metastases. Their management is dependent on an adequate incisional biopsy to assess the grade of the tumour. The biopsy incision must be carefully placed so as not to compromise subsequent radical excision. Of patients so treated, 20 to 30% experience local recurrence within the first 3 years postoperatively. The use of adjuvant radiotherapy decreases the incidence of local recurrence to about 15%. Patients with retroperitoneal sarcomas have a greater tendency to suffer recurrence, with disseminated disease throughout the abdomen. The overall 5-year survival rate is about 50%. Patients may, however, have persistent disease or develop metastases beyond the 5-year period. The optimal timing of radiation and chemotherapy remains unresolved, but multimodality treatment at least allows the advocation of limb-sparing procedures for patients with soft-tissue sarcomas.
软组织肉瘤是具有局部侵袭性的肿瘤,有通过血行转移的倾向,尤其是转移至肺部。大多数患者就诊时无明显转移。其治疗取决于充分的切开活检以评估肿瘤分级。活检切口必须精心设计,以免影响后续的根治性切除。接受此类治疗的患者中,20%至30%在术后头3年内会出现局部复发。辅助放疗的应用可将局部复发率降至约15%。腹膜后肉瘤患者复发倾向更大,会出现全腹播散性疾病。总体5年生存率约为50%。然而,患者可能会有持续性疾病或在5年之后发生转移。放疗和化疗的最佳时机仍未确定,但多模式治疗至少使为软组织肉瘤患者采用保肢手术成为可能。